Market News & Trends
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology
SIRION Biotech GmbH recently announced that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST for use in….
Cambrex Completes Biopharmaceutical Expansion at its Durham Facility
Cambrex recently announced it has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, NC, site. Biopharmaceutical analysis services were initially launched at…
Roquette Launches Online Technical Platform for Researchers & Drug Developers
As virtual collaboration and knowledge-sharing have reached a new level of urgency within the scientific community, Roquette, a trusted global supplier to life science companies…
Cytovia Therapeutics & Macromoltek to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
Cytovia Therapeutics recently announced it is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis. Natural Killer cells are a first…
Global Regulators Discuss Observational Studies of Real-World Data for COVID-19 Medicines
In a recent dedicated COVID-19 workshop, organized by the European Medicines Agency (EMA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA),…
Emisphere Announces Novo Nordisk Development Update
Novo Nordisk recently announced the European Commission (EC) has granted marketing authorization for Rybelsus, (oral semaglutide), for the treatment of adults with insufficiently controlled type…
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026
The global antiviral drugs market was valued at $56 billion in 2019 and is expected to accrue phenomenal gains over the forecast period. The spread…
Metrion Biosciences & International Scientific Consortium Publish Data & New Recommendations for In Vitro Risk Assessment of the Cardiac Safety of New Medicines
Metrion Biosciences Limited announced it has contributed to two new peer-reviewed papers under the US FDA CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative. The papers,…
Novavax Identifies COVID-19 Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Novavax, Inc. recently announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate…
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..
SGS Digicomply Launches AI System to Find Answers on COVID-19 Within Research Articles
SGS Digicomply recently announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding….
For a CDMO, Flexibility & Adaptability Are Key Attributes to Navigate the Evolving Healthcare Landscape
The healthcare landscape continues to change at a rapid pace. The strong growth in the number of complex drugs, new therapeutic approaches and technologies, pricing issues and….
N4 Pharma Provides Covid-19 Project & Operational Update
N4 Pharma Plc, the specialist pharmaceutical company developing Nuvec, a novel delivery system for cancer treatments and vaccines, recently announced it will be undertaking a…
Fast New Tests for Covid-19 on the Way
At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing citizens for Covid-19. Both techniques have…
NeuBase Therapeutics Announces Positive Preclinical Data
NeuBase Therapeutics, Inc. recently announced positive preclinical data from its pharmacokinetics studies in non-human primates (NHPs) and in vitro pharmacodynamics data in patient-derived cell lines.…
Oxford BioTherapeutics Announces Second Oncology Drug Candidate Selected to Advance Into Formal IND-Enabling Studies From Boehringer Ingelheim Collaboration
Oxford BioTherapeutics Ltd. recently announced that Boehringer Ingelheim has selected a second asset to advance into formal IND enabling studies. The asset discovery was enabled…
New Incentives & Benefits Can Boost R&D Ecosystem for New Drug Development in India
India has recently sought feedback from the top pharmaceutical companies to make regulatory changes that offer specific tax benefits for specialized research. With the government’s…
Malvern Panalytical & Concept Life Sciences Form Unique Partnership
Malvern Panalytical and Concept Life Sciences recently launched a new partnership that combines advanced instrumentation with expert analytical services for discovery and development. This collaboration…
Aravive Announces AVB-500 Improves Anti-Tumor Effects When Combined With Anti-Angiogenic Bevacizumab or PARP Inhibitor Olaparib
Aravive, Inc. recently announced that AVB-500 improves anti-tumor effects when combined with the anti-angiogenic bevacizumab or the PARP inhibitor olaparib in preclinical uterine cancer models.…
Carterra Selected by La Jolla Institute of Immunology to Provide Antibody Screening & Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
Carterra Inc. and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA platform to screen hundreds of antibodies in…
